Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Change in Intangibles (2021 - 2026)

Valneva SE (VALN) posted Change in Intangibles of -$5853.7 for Q1 2026, down 151.71% sequentially from $11319.6 in Q2 2025, and up 92.16% YoY from -$3046.2 in Q1 2025.

Analysis

Valneva SE (VALN) Change in Intangibles (2021 - 2026) Analysis & Trends

Valneva SE has reported Change in Intangibles for 6 years, with the latest figure at -$5853.7 in Q1 2026.

  • Quarterly Change in Intangibles rose 92.16% year-over-year to -$5853.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$69217.9 (up 7.32% YoY) and the FY2024 annual result came in at $98.3 million, up 112303.86% from the prior year.
  • Change in Intangibles declined to -$5853.7 in Q1 2026 per VALN's latest filing, from $11319.6 in the prior quarter.
  • Over five years, Change in Intangibles peaked at $98.7 million in Q1 2024 and troughed at -$87151.1 in Q4 2023.
  • A 5-year average of $16.4 million and a median of -$40268.8 in 2025 frame the typical range for Change in Intangibles.
  • The sharpest annual moves came in 2025 and 2026: Change in Intangibles plunged 100.08% in 2025, then surged 92.16% in 2026.
  • Over 5 years, Change in Intangibles stood at -$85297.7 in 2022, then decreased by 2.17% to -$87151.1 in 2023, then surged by 113325.72% to $98.7 million in 2024, then plunged by 99.99% to $11319.6 in 2025, then plunged by 151.71% to -$5853.7 in 2026.
  • According to Business Quant data, Change in Intangibles over the past three periods registered -$5853.7, $11319.6, and -$74683.8 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,853.73
Jun 30, 2025 11,319.60
Mar 31, 2025 -74,683.80
Mar 31, 2024 98.68 Mn
Dec 31, 2023 -87,151.13
Mar 31, 2022 -85,297.67
Dec 31, 2021 -4,575.88
Sep 30, 2021 -208,733.86